- Since its inception, Myriad has always taken "meeting customer needs" as the driving force for growth, and has gradually established an R&D management platform guided by customer needs and centered on project management, to stay close to the market to comprehensively understand user needs and quickly respond to them, and to integrate innovative technologies and R&D and production cost advantages to provide high-performance and price-performance products and services to medical institutions around the world, creating greater value for customers. With the integration of innovative technology and R&D and production cost advantages, we provide high performance-price ratio products and services to medical organizations worldwide, creating greater value for our customers.
- Micrel currently has six R&D centers in Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Stockholm. Nearly 30 percent of Myers employees work in the R&D system on a wide range of products with clinical applications.
- Myers insists on investing approximately 10% of its annual turnover to support product innovation and R&D, and has established an R&D management platform that is in line with international standards. Myriad has an R&D management process that complies with CE, FDA standards and ISO systems. The development process is controlled and managed by an expert committee, and all products are designed in accordance with relevant international standards during the product development process, and are verified by comprehensive special tests (including EMC, safety, and environmental tests), which ensure that the safety and reliability of the products are adequately safeguarded.
- In December 2002, the "National Engineering Research Center for Medical Diagnostic Instruments" of the Ministry of Science and Technology (MOST) was successfully established in Myriad. After 3 years of establishment and operation, the center was officially established in 2006 by the Ministry of Science and Technology of the People's Republic of China. This marks a new mechanism for Myriad to lead and enhance the technology development process of the domestic medical equipment industry.
Major tasks of the National Engineering Center: Expected results of the National Engineering Center:
Actively participate in the construction of industry regulations and standards
Master the core technology and launch high-tech products
Provide mature and supporting technology for industrialized production
Provide the key technology and components to the industry
Become a training base for talents in this industry Talent training base Assist in improving industry regulations and promoting industry development
Breakthroughs in core technology research
Opening up services to drive the development of the whole industry
Promoting the export of high-tech medical equipment -Focusing on the forefront of global technology, every product developed by Myriad is born out of the concept of user-centered design Since 1992, Myriad has made significant contributions in the areas of life information and support, clinical testing, digital ultrasound, clinical diagnostics, and medical technology, as well as in the development and manufacture of medical equipment. Since 1992, in the four major fields of life information and support, clinical testing, digital ultrasound, and radiology imaging, Myriad has successively launched more than 70 new products, possessing all independent intellectual property rights and more than 960 patented technologies, filling the gaps in domestic scientific research and development, and creating a number of China's "firsts".
- Life Information and Support
1992 China's first oximetry monitor
1993 China's first multi-parameter monitor
1994 China's first central monitoring system
1998 China's first portable multi-parameter monitor
2003 China's first wireless central monitoring system
Wireless central monitoring system China's first wireless central monitoring system
2006 China's first modular information monitor
2006 China's first anesthesia machine integrating multi-parameter monitoring and informationization
2009 China's first biphasic defibrillator with fully independent intellectual property rights
- Clinical Tests and Reagents
1998 China's first quasi-automatic blood cell analyzer
2001 China's first automatic blood cell analyzer
2003 China's first automatic biochemistry analyzer
2005 China's first automatic blood cell analyzer with closed puncture sampling
2006 China's first automatic five-category blood cell analyzer
Clinical testing and reagents
Clinical testing and reagents
1998 Analyzer
2010 China's first high-speed automatic biochemical line
- Digital Ultrasound
1993 China's first transcranial Doppler cerebral blood flow diagnostic instrument
2001 China's first all-digital, high-grade, black-and-white ultrasound diagnostic instrument
2004 China's first all-digital portable ultrasound diagnostic instrument
2006 China's first all-digital portable ultrasound diagnostic instrument
The first fully automatic blood cell analyzer in China.
2006 China's first desktop color Doppler ultrasound system with fully independent intellectual property rights
2008 China's first portable color Doppler ultrasound system with fully independent intellectual property rights
2009 China's first mid- to high-end desktop color Doppler ultrasound system with fully independent intellectual property rights